title: Protocol for ADDITION-PRO: a longitudinal cohort study of the cardiovascular experience of individuals at high risk for diabetes recruited from Danish primary care.
abstract: BACKGROUND
  Screening programmes for type 2 diabetes inevitably find more individuals at high risk for diabetes than people with undiagnosed prevalent disease. While well established guidelines for the treatment of diabetes exist, less is known about treatment or prevention strategies for individuals found at high risk following screening. In order to make better use of the opportunities for primary prevention of diabetes and its complications among this high risk group, it is important to quantify diabetes progression rates and to examine the development of early markers of cardiovascular disease and microvascular diabetic complications. We also require a better understanding of the mechanisms that underlie and drive early changes in cardiometabolic physiology. The ADDITION-PRO study was designed to address these issues among individuals at different levels of diabetes risk recruited from Danish primary care.
  
  
  METHODS
  ADDITION-PRO is a population-based, longitudinal cohort study of individuals at high risk for diabetes. 16,136 eligible individuals were identified at high risk following participation in a stepwise screening programme in Danish general practice between 2001 and 2006. All individuals with impaired glucose regulation at screening, those who developed diabetes following screening, and a random sub-sample of those at lower levels of diabetes risk were invited to attend a follow-up health assessment in 2009-2011 (n=4,188), of whom 2,082 (50%) attended. The health assessment included detailed measurement of anthropometry, body composition, biochemistry, physical activity and cardiovascular risk factors including aortic stiffness and central blood pressure. All ADDITION-PRO participants are being followed for incident cardiovascular disease and death.
  
  
  CONCLUSIONS
  The ADDITION-PRO study is designed to increase understanding of cardiovascular risk and its underlying mechanisms among individuals at high risk of diabetes. Key features of this study include (i) a carefully characterised cohort at different levels of diabetes risk; (ii) detailed measurement of cardiovascular and metabolic risk factors; (iii) objective measurement of physical activity behaviour; and (iv) long-term follow-up of hard clinical outcomes including mortality and cardiovascular disease. Results will inform policy recommendations concerning cardiovascular risk reduction and treatment among individuals at high risk for diabetes. The detailed phenotyping of this cohort will also allow a number of research questions concerning early changes in cardiometabolic physiology to be addressed.
authors.affiliation: Steno Diabetes Center A/S, Gentofte, Denmark.
authors.forename: Nanna B
authors.initials: NB
authors.lastname: Johansen
authors.forename: Anne-Louise S
authors.initials: AL
authors.lastname: Hansen
authors.forename: Troels M
authors.initials: TM
authors.lastname: Jensen
authors.forename: Annelotte
authors.initials: A
authors.lastname: Philipsen
authors.forename: Signe S
authors.initials: SS
authors.lastname: Rasmussen
authors.forename: Marit E
authors.initials: ME
authors.lastname: Jørgensen
authors.forename: Rebecca K
authors.initials: RK
authors.lastname: Simmons
authors.forename: Torsten
authors.initials: T
authors.lastname: Lauritzen
authors.forename: Annelli
authors.initials: A
authors.lastname: Sandbæk
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Witte
mesh_terms: D000328:Adult; D000368:Aged; D001786:Blood Glucose; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D002985:Clinical Protocols; D003718:Denmark / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology* / Q000473:pathology; D018450:Disease Progression; D005215:Fasting / Q000097:blood; D005260:Female; D018149:Glucose Intolerance; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D011320:Primary Health Care / Q000379:methods*; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D001786:Blood Glucose